Medication Adherence Therapy for Opioid Abusing Pain Patients

Completed · Phase 1/Phase 2

Conditions studied: Pain, Chronic Disease, Prescription Opioid Abuse

In brief

The purpose of this study is to develop and pilot test a combined behavioral and pharmacological intervention designed to decrease pain, functional interference, and drug abuse while increasing medication adherence.

Key facts

Study ID

NCT00249587

Run by

National Institute on Drug Abuse (NIDA)

People needed

36

Starts

2000-09-01

Expected to finish

2005-09-01

Last updated by the study team

2017-01-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Uninterrupted pain of at least 6 months duration
• Pain is continuous, rather than intermittent
• Pain in the severe range (VAS = 7-10) while medicated
• Poor response to non-pharmacological interventions for pain (if appropriate)
• One or more of the following pain diagnoses: (a) back/neck pain; (b) myofacial pain; (c) neuropathic pain (e.g., diabetic or AIDS neuropathy, Complex regional pain syndrome); (d) arthritic pain; (e) MS; or (f) sickle cell (must meet chronicity criteria)
• Evidence of tolerance/physiological dependence on opioid analgesics
• Current opioid use disorder (DSM-IV criteria)
• Continuous use of opioid analgesics for a minimum of 6 months prior to referral. [Note: This is consistent with minimum 6-month requirement for diagnosis of chronic pain].
• Minimum of 2 signs/symptoms of medication mismanagement identified by the Referring MD (PROBLEMS WITH PAIN MEDS checklist)

You may not qualify if…

• Please contact site regarding exclusion criteria for this study.

Where it is running

• Behavioral Science Research Unit — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.